Literature DB >> 29658071

Pathological Remodeling of the Myocardium in Chronic Heart Failure: Role of PGC-1α.

T G Kulikova1, O V Stepanova2, A D Voronova2, M P Valikhov2, V N Sirotkin2, I V Zhirov2, S N Tereshchenko2, V P Masenko2, A N Samko2, G T Sukhikh3.   

Abstract

Pathological remodeling of the myocardium in chronic heart failure includes the development of pathological cardiac hypertrophy, reactivation of the fetal genetic program, and disorders in cardiac energy metabolism. Coactivator-1α of receptor γ activated by peroxisome proliferator (PGC-1α), a transcription coactivator of nuclear receptors and metabolism master regulator, plays an important role in cardiac metabolism regulation. Studies on the animals models of chronic heart failure have demonstrated the development of pathological cardiac hypertrophy, metabolic disorders, and reactivation of the fetal genetic program; these processes are mutually related. An important role in regulation of these processes belongs to PGC-1α; its low expression indicates low activity and down-regulation of this coactivator. Pathological cardiac hypertrophy, decrease of PGC-1α activity, and reactivation of the fetal genetic program in chronic heart failure are demonstrated.

Entities:  

Keywords:  PGC-1α; fetal cardiomyocytes; fetal genetic program; myocardial energy metabolism; pathological cardiac hypertrophy

Mesh:

Substances:

Year:  2018        PMID: 29658071     DOI: 10.1007/s10517-018-4082-1

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  6 in total

1.  Fine-Tuning of PGC1α Expression Regulates Cardiac Function and Longevity.

Authors:  Xudong Zhu; Weiyan Shen; Ke Yao; Hu Wang; Bo Liu; Tangliang Li; Lijuan Song; Daojun Diao; Genxiang Mao; Ping Huang; Chengtao Li; Hongbo Zhang; Yejun Zou; Yugang Qiu; Yuzheng Zhao; Wengong Wang; Yi Yang; Zeping Hu; Johan Auwerx; Joseph Loscalzo; Yong Zhou; Zhenyu Ju
Journal:  Circ Res       Date:  2019-08-15       Impact factor: 17.367

2.  Low-dose Dasatinib Ameliorates Hypertrophic Cardiomyopathy in Noonan Syndrome with Multiple Lentigines.

Authors:  Jae-Sung Yi; Sravan Perla; Yan Huang; Kana Mizuno; Frank J Giordano; Alexander A Vinks; Anton M Bennett
Journal:  Cardiovasc Drugs Ther       Date:  2021-03-10       Impact factor: 3.947

3.  Shengmai Injection Suppresses Angiotensin II-Induced Cardiomyocyte Hypertrophy and Apoptosis via Activation of the AMPK Signaling Pathway Through Energy-Dependent Mechanisms.

Authors:  Yiping Li; Xiaofen Ruan; Xiaowen Xu; Cha Li; Tingting Qiang; Hua Zhou; Junjie Gao; Xiaolong Wang
Journal:  Front Pharmacol       Date:  2019-09-20       Impact factor: 5.810

4.  Ubiquitin Pathway Is Associated with Worsening Left Ventricle Function after Mitral Valve Repair: A Global Gene Expression Study.

Authors:  Feng-Chun Tsai; Gwo-Jyh Chang; Ying-Ju Lai; Shang-Hung Chang; Wei-Jan Chen; Yung-Hsin Yeh
Journal:  Int J Mol Sci       Date:  2020-07-18       Impact factor: 5.923

Review 5.  Regulation of Mitochondrial Dynamics by Aerobic Exercise in Cardiovascular Diseases.

Authors:  Changping Gu; Jie Yan; Liang Zhao; Guanghan Wu; Yue-Lan Wang
Journal:  Front Cardiovasc Med       Date:  2022-01-13

6.  Effect of the Shensong Yangxin Capsule on Energy Metabolism in Angiotensin II-Induced Cardiac Hypertrophy.

Authors:  Bei-Lei Liu; Mian Cheng; Shan Hu; Shun Wang; Le Wang; Zheng-Qing Hu; Cong-Xin Huang; Hong Jiang; Gang Wu
Journal:  Chin Med J (Engl)       Date:  2018-10-05       Impact factor: 2.628

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.